SARS-CoV-2	Severe acute respiratory syndrome coronavirus 2
COVID-19	Coronavirus disease 2019
PP	Pooled prevalence
CI	Confidence interval
OR	Odds ratio
ICU	Intensive care unit
LOS	Length of stay
COPD	Chronic obstructive pulmonary diseases
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PFT	Pulmonary functional test
WHO	World Health Organization
UK	United Kingdom
CT	Computerized tomography
DLCO	Carbon monoxide diffusing capacity
mMRC	Modified Medical Research Council Dyspnea Scale
GI	Gastrointestinal
GAD-7	Generalized anxiety disorder-7
PTSD	Post-traumatic stress disorder
6 MWT	6-min walk test
EQ-5D-5L	European Quality of Life Five-Dimension Five-Level Scale
GGO	Ground-glass opacity
FVC	Forced vital capacity
FEV1	Forced expiratory volume in one second
VC	Vital capacity
FEV1/FEV	Forced expiratory volume in one second/forced expiratory volume
TLC	Total lung capacity
GRADE	Grading of Recommendations, Assessment, Development, and Evaluation
RR	Risk Ratio